Abstract

The session will provide an overview on the role of microRNAs and other non-coding RNAs in promoting cancer initiation and progression in solid and hematological malignancies. The session will also highlight potential clinical applications of non-coding RNAs as prognostic, predictive and early diagnosis biomarkers. Talks will range from the basic understanding of non-coding RNA function and regulation to the potential clinical applications in diagnosis and therapy. The session is intended for a broad audience of basic and translational scientists and clinicians. Learning objectives: 1.Understanding the role of the non-coding genome in regulating cancer progression. 2.Understanding potential benefits and pitfalls of the application of microRNAs in a clinical setting. 3.Networking with experts in the field of non-coding RNA and establishing scientific collaborations.